Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  ESSILOR INTL.    EI   FR0000121667

Real-time Quote. Real-time Tradegate - 01/19 08:10:40 pm
110.854 EUR   -2.33%
01/17 LUXOTTICA : in euro46bln merger with French lens maker Essilor
01/17 ESSILOR INTL : and Delfin to create a global integrated player in th..
01/17 ESSILOR INTL : £40bn Ray-ban merger
News SummaryMost relevantAll newsSector newsTweets 

ESSILOR INTL. : Essilor Continues to Expand in the United States

share with twitter share with LinkedIn share with facebook
share via e-mail
01/31/2013 | 06:35am CET

Regulatory News:

Essilor (Paris:EI) is continuing to strengthen its positions in the United States, the world's leading market for ophthalmic lenses, with the acquisition of a lens manufacturer and a new prescription laboratory.

The Company has announced the acquisition of an 80% share in X-Cel Optical, a manufacturer of ophthalmic lenses based in Minnesota (US). Leveraging its widely recognized, high performance technical expertise, X-Cel Optical offers a wide range of niche products, the vast majority of which are bi- and tri-focal, stock and variable-tint lenses. The line-ups are produced in various materials, including Trivex?. With a refraction index of 1.53 and impact resistance comparable to that of polycarbonate, Trivex? is enjoying rapid sales growth.

X-Cel Optical produces just over two million lenses a year and generates full-year revenue of approximately $33 million.

The development of the X-Cel Optical product line, which fits very well with Essilor's, will be led by the Group's various distribution networks in the United States, comprising both proprietary and independent laboratories, and around the world. The X-Cel Optical offer may also be moved upmarket, using Essilor's leading-edge technologies, in particular the Crizal® range of surface coatings, as a lever.

In addition, the partnership will enable Essilor to optimize its sourcing strategy. Lastly, Essilor and X-Cel Optical may also share their engineering skills and capabilities to optimize their production processes.

Essilor is also continuing to deepen its local distribution network in the United States to capture the market's growth potential for value-added lenses. The Company has signed a partnership with Lenstech Optical, a prescription laboratory in Indiana that generates annual revenue of $6 million.

In the future, Essilor will activate the usual value-creation levers by providing Lenstech Optical with new technologies that will speed the distribution of its flagship brands, including Varilux® and Crizal®, in the partner's catchment area.

About Essilor

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates around ?150 million to research and development every year, in a commitment to continuously bring new, more effective products to market. Essilor's flagship brands are Varilux®, Crizal®, Definity®, Xperio®, Optifog? and Foster Grant®. It also develops and markets equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of ?4.2 billion in 2011 and employs around 48,700 people in some 100 countries. It operates 19 plants, a total of 390 prescription laboratories and edging facilities, as well as several research and development centers around the world.

For more information, please visit www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the EuroStoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

Investor Relations and
Financial Communication
Véronique Gillet ? Sébastien Leroy ? Ariel Bauer
Phone: +33 (0)1 49 77 42 16
Media Relations
Maïlis Thiercelin
Phone: +33 (0)1 49 77 45 02

© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ESSILOR INTL.
01/17 LUXOTTICA : in euro46bln merger with French lens maker Essilor
01/17 ESSILOR INTL : and Delfin to create a global integrated player in the eyewear in..
01/17 ESSILOR INTL : £40bn Ray-ban merger
01/17 ESSILOR INTL : Ray-Ban owner Luxottica agrees 46bn merger with French lens maker..
01/17 ESSILOR INTL : Ray-Ban firm in Pounds 40bn merger
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/17 LUXOTTICA : Ray-Ban owner Luxottica agrees €46bn merger with French lens firm
01/16 LUXOTTICA : Glasses maker Luxottica to merge with lens manufacturer Essilor
More news
Sector news : Glasses, Spectacles & Contact lenses
01/10DJSTRYKER : Expects Annual Profit at High End of Projections
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Glasses, Spectacles & Contact lenses
News from SeekingAlpha
01/18 LUXOTTICA AND ESSILOR : Bullish On The Company, But Not On The Stock
01/17 Essilor International SA (ESLOY) Investor Presentation - Slideshow
01/17 Essilor & Luxottica Merger Creates An Eyewear Giant - No Opportunities For In..
01/17 WALL STREET BREAKFAST : Theresa May's Brexit Speech
01/16 Luxottica, Essilor create ?50B eyewear giant
Financials (€)
Sales 2016 7 097 M
EBIT 2016 1 263 M
Net income 2016 816 M
Debt 2016 1 791 M
Yield 2016 1,06%
P/E ratio 2016 30,02
P/E ratio 2017 26,65
EV / Sales 2016 3,75x
EV / Sales 2017 3,40x
Capitalization 24 792 M
More Financials
Duration : Period :
ESSILOR INTL. Technical Analysis Chart | EI | FR0000121667 | 4-Traders
Full-screen chart
Technical analysis trends ESSILOR INTL.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 122 €
Spread / Average Target 7,7%
Consensus details
EPS Revisions
More Estimates Revisions
Hubert Sagnières Chairman & Chief Executive Officer
Laurent Vacherot President & Chief Operating Officer
Paul du Saillant Co-Chief Operating Officer
Jean Carrier-Guillomet Chief Operating Officer
Géraldine Picaud Chief Financial Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ESSILOR INTL.5.73%26 382
INTEROJO CO. LTD.--.--%332
More Results